PMGC Holdings ELAB
NASDAQ ELAB
$6.34 +0.24 (+3.93%)
As of: Aug 21, 2026 · 10:10 AM EDT

PMGC Holdings (ELAB) Total Current Liabilities (2022 - 2026)

PMGC Holdings (ELAB) posted Total Current Liabilities of $11.3 million for Q1 2026, up 186.58% sequentially from $3.9 million in Q4 2025, and up 1386.02% YoY from $760268.0 in Q1 2025.

PMGC Holdings (ELAB) Total Current Liabilities (2022 - 2026) Analysis & Trends

PMGC Holdings has reported Total Current Liabilities for 5 years, with the latest figure at $11.3 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 1386.02% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (up 1386.02% YoY) and the FY2025 annual result came in at $3.9 million, up 119.12% from the prior year.
  • Total Current Liabilities advanced to $11.3 million in Q1 2026 per ELAB's latest filing, from $3.9 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $1.6 billion in Q3 2023 and troughed at $326301.0 in Q2 2025.
  • A 5-year average of $139.5 million and a median of $1.9 million in 2024 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2026: Total Current Liabilities plunged 99.87% in 2024, then surged 1386.02% in 2026.
  • Over 5 years, Total Current Liabilities stood at $588272.0 in 2022, then surged by 120.54% to $1.3 million in 2023, then jumped by 38.68% to $1.8 million in 2024, then jumped by 119.12% to $3.9 million in 2025, then jumped by 186.58% to $11.3 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $11.3 million, $3.9 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.81 Bn 131.96 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 86.33 Bn 78.34 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 65.13 Bn 59.95 Bn 1.37 Bn 1.58 Bn
4 Moderna 60.47 Bn 55.33 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 31.04 Bn 27.73 Bn 992.69 Mn 1.51 Bn
7 BioNTech SE 28.48 Bn 10.09 Bn 668.28 Mn 2.49 Bn
8 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 438.74 Mn
9 Royalty Pharma 27.23 Bn 26.39 Bn - 630.93 Mn
10 PMGC Holdings 30.87 Mn 12.08 Mn 385,691.00 15.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.30 Mn
Dec 31, 2025 3.94 Mn
Sep 30, 2025 5.46 Mn
Jun 30, 2025 326,301.00
Mar 31, 2025 760,268.00
Dec 31, 2024 1.80 Mn
Sep 30, 2024 2.13 Mn
Jun 30, 2024 1.94 Mn
Mar 31, 2024 1.22 Mn
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.64 Bn
Dec 31, 2022 588,272.00